Drug Discovery Research
Related Articles
- Dec 18, 2011 -
HNF to fund promising research on Charcot-Marie-Tooth: Planning, shopping, wrapping, baking--December can be so exhausting. In the middle of all the holiday activity, HNF would like to stop and shout a huge “thank you” to our supporters! Please read the l Read More... - Dec 6, 2011 - CMT Research Update: HNF-Funded Projects: HNF puts your dollars to work! We are currently funding two very important research projects, one for CMT type 1 and the other for CMT type 2A.
Charcot-Marie-Tooth, Type 1
CMT type 1 is caused b Read More...
Too often, important scientific discoveries never enter the pharmaceutical research phase due to lack of guidance, interest, or incentive. At HNF, we are not only committed to funding cutting-edge basic science research, we are also committed to seeing that our research is continued by pharmaceutical companies with the goal of producing a drug that can cure or treat CMT. In order to ensure that our research is continued on the pharmaceutical level, HNF is already working with pharmaceutical consultants to ensure that our research is being completed to industry standard. We have also structured our strategy to ensure that there is sufficient scientific and financial interest on the part of the pharmaceutical companies.
HNF is particularly grateful to Dr. Jay Tung, a Member of HNF’s Medical Advisory Board and the Vice-President of Drug Discovery at the Myelin Repair Foundation, for his guidance and expertise. HNF is impressed with the Myelin Repair Foundation’s innovative approach to research and their mechanism for driving research forward in the area of Multiple Sclerosis.
Recent Comments